A. Groenewegen

The selective sphingosine 1‐phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species‐specific effects on heart rate

P Gergely, Barbara Nuesslein‐Hildesheim, Danilo Guerini et al. · British Journal of Pharmacology · 2012 · 304 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Pharmacokinetics, pharmacodynamics and safety of <scp>QGE</scp>031 (ligelizumab), a novel high‐affinity anti‐IgE antibody, in atopic subjects

Jonathan Arnold A. P., I. Bottoli, Andrej Skerjanec et al. · Clinical & Experimental Allergy · 2014 · 241 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17

Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study.

Pieter Sonneveld, J. P. Marie, C. Huisman et al. · PubMed · 1996 · 95 citations

Medicine, Oncology, Pharmacology +15

Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial

J.M.L. Stouthard, H Goey, PH de Mulder et al. · British Journal of Cancer · 1996 · 42 citations · Full text

Medicine, Immunology, Oncology +16

Recombinant human interleukin-3 (rH IL-3) in combination with remission induction chemotherapy in patients with relapsed acute myelogenous leukemia (AML): a phase I/II study.

JJ Wielenga, Edo Vellenga, A. Groenewegen et al. · PubMed · 1996 · 14 citations

Medicine, Immunology, Oncology +17